{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:30:11Z","timestamp":1791613811588,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011541","name":"National Cancer Institute Division of Cancer Epidemiology and Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ygyno.2021.04.036","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T08:20:22Z","timestamp":1620634822000},"page":"134-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The impact of race, comorbid conditions and obesity on survival endpoints in women with high grade endometrial carcinoma"],"prefix":"10.1016","volume":"162","author":[{"given":"Juliana","family":"Fucinari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Elshaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie J.","family":"Ruterbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remonda","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Dyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Shultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouba","family":"Ali-Fehmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele L.","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.04.036_bb0010","author":"Centers for Disease Control and Prevention"},{"issue":"11","key":"10.1016\/j.ygyno.2021.04.036_bb0015","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting Cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ygyno.2021.04.036_bb0020","article-title":"Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis","volume":"221","author":"Doll","year":"2019","journal-title":"Am J Obstet Gynocol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.04.036_bb0025","first-page":"287","article-title":"Risk factors for endometrial cancer in black and white women: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2)","volume":"26","author":"Cote","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.ygyno.2021.04.036_bb0030","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"issue":"10023","key":"10.1016\/j.ygyno.2021.04.036_bb0035","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet."},{"issue":"22","key":"10.1016\/j.ygyno.2021.04.036_bb0040","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.19.00151","article-title":"Hysterectomy-corrected uterine Corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of Nonendometrioid cancers","volume":"37","author":"Clark","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.04.036_bb0045","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ygyno.2013.05.020","article-title":"Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States","volume":"130","author":"Long","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2021.04.036_bb0050","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/1055-9965.EPI-15-0316","article-title":"The growing burden of endometrial cancer: a major racial disparity affecting black women","volume":"24","author":"Cote","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.ygyno.2021.04.036_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ygyno.2012.10.016","article-title":"The impact of race on outcomes of patients with early stage uterine endometrioid carcinoma","volume":"128","author":"Elshaikh","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.04.036_bb0060","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajog.2017.09.016","article-title":"Endometrial cancer disparities: a race-conscious critique of the literature","volume":"218","author":"Doll","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.04.036_bb0065","article-title":"NCCN guidelines for treatment of cancer by site: Uterine Neoplasms, Version 1.2003","author":"National Comprehensive Cancer Network","year":"2003","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ygyno.2021.04.036_bb0070","article-title":"NCCN guidelines for treatment of cancer by site: Uterine Neoplasms, Version 1.2007","author":"National Comprehensive Cancer Network","year":"2007","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"5","key":"10.1016\/j.ygyno.2021.04.036_bb0075","article-title":"NCCN guidelines for treatment of cancer by site: Uterine Neoplasms, Version 1.2009","volume":"7","author":"National Comprehensive Cancer Network","year":"2009","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"2","key":"10.1016\/j.ygyno.2021.04.036_bb0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.6004\/jnccn.2014.0025","article-title":"NCCN guidelines for treatment of cancer by site: uterine neoplasms, version 1.2014","volume":"12","author":"National Comprehensive Cancer Network","year":"2014","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"5","key":"10.1016\/j.ygyno.2021.04.036_bb0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in logitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Ds."},{"issue":"2","key":"10.1016\/j.ygyno.2021.04.036_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2013.12.039","article-title":"Gynecologic cancer disparities: a report from the health disparities taskforce of the Society of Gynecologic Oncology","volume":"133","author":"Collins","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.04.036_bb0095","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ygyno.2012.08.025","article-title":"Histopathologic differences account for racial disparity in uterine cancer survival","volume":"127","author":"Smotkin","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2021.04.036_bb0100","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1002\/cncr.22351","article-title":"Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a gynecologic oncology group study","volume":"107","author":"Von Gruenigen","year":"2006","journal-title":"Cancer."},{"issue":"1","key":"10.1016\/j.ygyno.2021.04.036_bb0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ygyno.2015.10.020","article-title":"Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis","volume":"140","author":"Secord","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.04.036_bb0110","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ijo.2012.94","article-title":"Obesity and endometrial cancer survival: a systematic review","volume":"37","author":"Arem","year":"2013","journal-title":"Int. J. Obes."},{"issue":"4","key":"10.1016\/j.ygyno.2021.04.036_bb0115","first-page":"337","article-title":"The impact of comorbidity on cancer and its treatment","volume":"66","author":"Sarfati","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.ygyno.2021.04.036_bb0120","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/cncr.28509","article-title":"Annual report to the nation on the status of cancer 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer","volume":"120","author":"Edwards","year":"2014","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.ygyno.2021.04.036_bb0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/aje\/kws580","article-title":"Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence","volume":"178","author":"Cho","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.04.036_bb0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/COC.0000000000000129","article-title":"Influence of comorbidity on the risk of death: a single institution study of 1132 women with early-stage uterine cancer","volume":"40","author":"Elshaikh","year":"2017","journal-title":"Am. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.04.036_bb0135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.32740","article-title":"Guideline-concordant endometrial cancer treatment and survival in the Women\u2019s Health Initiative life and longevity after cancer study","volume":"147","author":"Felix","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2021.04.036_bb0140","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ygyno.2020.03.016","article-title":"Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer","volume":"157","author":"Dholakia","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.04.036_bb0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2014.02.011","article-title":"Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis","volume":"133","author":"Vargas","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.04.036_bb0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2012.10.009","article-title":"Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer","volume":"128","author":"Alhilli","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.04.036_bb0155","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2017.01.024","article-title":"Disparities in receipt of care for high-grade endometrial cancer: a National cancer data base analysis","volume":"145","author":"Bregar","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2021.04.036_bb0160","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1002\/cam4.1742","article-title":"Racial disparities in outcomes for high-grade uterine cancer: a California cancer registry study","volume":"7","author":"Baskovic","year":"2018","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.ygyno.2021.04.036_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(13)70591-6","article-title":"Classification of endometrial carcinoma: more than two types","volume":"15","author":"Murali","year":"2014","journal-title":"Lancet Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821003565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821003565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:56:28Z","timestamp":1758772588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821003565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0090825821003565"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.04.036","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of race, comorbid conditions and obesity on survival endpoints in women with high grade endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}